Dietary restriction (DR) robustly extends lifespan and delays age-related diseases across 28
Results 117
Genetic variation in diet-dependent changes in lifespan. To determine the effects of genetic 118 variation on DR-mediated changes in lifespan, we reared ~200 non-virgin females in eight vials 119 from 161 DGRP lines on two dietary conditions that featured a ten-fold variation in dietary yeast. 120
Our DR condition contained 0.5% yeast extract and ad libitum (AL) diet, 5% yeast extract as 121 described previously (4, 77). We observed a broad range in diet-dependent changes in lifespan 122 across the strains, ranging from a 65% reduction in median lifespan from AL to DR to a 12.5-123
fold increase (Fig. 1A) . 83% of all lines survived longer on DR than on the AL diet ( Fig. 1B) . Out 124 of the longer-lived DGRP strains on an AL diet (>35 days median lifespan), less than 46% 125 received additional longevity benefits by DR, whereas 82% or shorter-lived strains (<35 days 126 median lifespan) showed increased median lifespan when undergoing DR. We repeated 127 lifespan measurements of 52 strains and saw largely reproducible median lifespans (Fig. 1C , R 2 128 = 0.57 for AL, R 2 = 0.64 for DR). In agreement with prior reports (28, 31, 78), we observed that 129 DR extends lifespan in most, but not all, strains. We also observed that overall DR was less 130 effective in extending the lifespan of strains that were already relatively long-lived. 131
Decline in negative geotaxis with age varies by genotype and diet. In addition to measuring 132 lifespan, we were interested in determining the genetic basis of functional health across the 133 DGRP, as identifying means to alter health can substantially improve the quality of life. Because 134
walking speed is frequently used as a marker of health and a predictor of mortality in humans 135
(79, 80), we utilized flies' natural tendency to climb their enclosure to track negative geotaxis 136 performance in 156 DGRP lines throughout the duration of their life in parallel to measuring 137 lifespan, as described above. We measured the percentage of each line able to climb an empty 138 vial wall once per week throughout adulthood (81-83) (detailed in Methods). As an index of 139 health decline, we analyzed the day at which a given DGRP strain fell below 50% of its initial 140 climbing ability. Some strains fell below this threshold within the first week after being placed on 141 DR or AL while others maintained greater than 50% climbing capacity for longer than 60 days 142 ( Fig. 2A ). Consistent with previous reports, we found that DR generally improved physical 143
activity. We observed that DR delayed the age-related decline in climbing ability in 69% of all 144 tested lines, with another 25% of lines showing no difference between the two diets ( Fig. 2B) . 145
Since normalizing to initial climbing ability removed the variation in the absolute climbing ability, 146
we also analyzed the changes in the absolute percentage of flies that were capable of climbing 147 across strains. For this trait, we recorded the day at which the percentage of surviving animals 148 able to climb fell under 20% (Fig. 2C , Suppl. Fig. 1 ). DR extended the length of time above 20% 149 climbing ability over AL in 87% of lines, with 12% of lines declining at the same day of life 150 regardless of diet ( Fig. 2D ). For both climbing measures we re-tested 17 lines and found our 151 recorded values to be reproducible ( Fig. 2E -F, R 2 = 0.62 for AL 50% decline and 0.63 for DR, R 2 152 = 0.76 for AL day below 20% climbing and 0.50 for DR). Together, these results indicate that 153 DR generally improves climbing ability, but the degree to which it is beneficial varies by 154
genotype. 155
Lack of correlation between recorded lifespan and climbing values. To better understand 156
the relationship between healthspan and lifespan, we compared the relationship between 157 median lifespan and age-related climbing ability. Separating the strains on AL into the longer-158 lived half of strains (>35 days median lifespan) and shorter-lived (<35 days), we found that the 159 average day of Across the shorter-lived half of the strains on the AL diet (<35 days median 160 lifespan) the average median lifespan was 23.9 days and the average day these strains reach 161
half of their initial climbing ability was 19.4, meaning on average these strains maintained better 162 than half their initial climbing ability for 81.2% of their average median lifespan. Across longer-163 lived strains on AL conditions (>35 days median lifespan), the average median lifespan was 38 164 days and the average normalized day of climbing decline was 22.9, 60% of the average median 165 lifespan ( Fig 3A) . On the DR diet, the shorter-lived strains (<39 median lifespan) had an 166 average median lifespan of 30.7 days and average day of climbing decline 28.2, maintaining 167
climbing ability for an elevated 91.9% of their lives. In long-lived strains (>39 days median 168 lifespan), the average median lifespan was 46.8 days and the average day of climbing decline 169 was 33.9, or only 72.4% of the average median lifespan (Fig. 3B ). Looking deeper into these 170 phenotypes across the individual strains, we found no evidence of a correlation between median 171 lifespan and 50% climbing decline on the AL across individual strains ( Fig. 3C , R 2 = 0.05), nor 172 the DR diet ( Fig. 3D , R 2 = 0.07). Similarly, we found no correlation between median lifespan and 173 our absolute climbing decline value (Suppl. Fig. 2 , AL R 2 = -0.06, DR R 2 = -0.01). We also 174 looked into responsiveness of each DGRP strain to DR, and found that across all of the strains, 175
only 50% of all strains showed >3 days improvement in both lifespan and days of life above 176 50% initial climbing capacity in response to DR. Alternatively, 14% of strains showed opposing 177 phenotypes, either with reduced climbing ability and increased lifespan on DR, or vice-versa. 178
The remaining 36% showed no change in either or both phenotypes ( Fig. 3E ). We found no 179 evidence of a correlation between change in climbing ability and change in median lifespan in 180 response to DR ( Fig. 3F , R 2 = -0.04). Together, these results imply that though DR overall 181 extends lifespan and healthspan, when examined across the individual DGRP strains these two 182 traits fail to correlate in our data. 183 Genome-wide association analysis. Next, we determined the genetic basis for the phenotypic 184 differences in median lifespan and climbing ability across the DGRP. We performed genome-185
wide association studies (GWAS) using a linear regression model with terms for genotype, diet, 186 and the interaction between genotype and diet as described in the Methods (called "Interaction" 187 terms). We identified a list of candidate loci with a minor allele frequency ≥25% with statistical 188 signals of ≤10% FDR based on permutation analysis ( and CR45580 (one variant) in interaction with diet. GWAS also identified a variant in CG5888 as 196 regulating longevity in a diet-independent manner based on genotype alone (Table 1) . 197
We next searched for loci that associated with exceptional longevity (see Methods) as an 198
additional screen for genetic variants that contributed to the extreme length of life rather than an 199 increased median lifespan. For this, we determined the upper 15 th percentile of longevity across 200 all tested strains (>41 days median lifespan on AL and >51 days on DR) as our "long-lived" 201 lines. This restructured "Case/Control" GWAS detected an association between DR longevity 202 and a polymorphism in Ferredoxin 1 (Fdxh) as well as two variants downstream of CG15515 203
and one intronic variant in CG5778 (Table 1) . 204
To further examine the relationship between lifespan and healthspan, we determined the 205 genetic loci associated with changes in climbing ability. GWAS for the day of 50% climbing 206 decline from initial climbing ability identified one significant polymorphism upstream of the non-207 protein coding gene CR43930 (Table 1 ). For the day at which fewer than 20% of surviving flies 208 could climb, GWAS identified seven polymorphisms downstream of dls to be significantly 209 associated with climbing in a diet-dependent manner ( Table 1) . 210
Diet and tissue-specific changes in dls, jgh, and Fdxh. We conducted a preliminary RNAi 211 screen with all of our candidate genes to determine how altered candidate gene expression 212 could impact longevity or climbing ability. With the use of the whole-body expression driver 213
Act5C-GS, we induced RNAi in five of the candidate genes indicated through GWAS (Suppl. 214 Fig. 3 ). We found that whole-body RNAi of CR32111 resulted in a 10% reduction in median 215 lifespan on DR but no change on AL (Suppl. Fig. 3A ). RNAi of CG8312 resulted in a slight, 3% 216 reduction of median lifespan on DR and a 7% extension in life on AL (Suppl. Fig. 3B ). RNAi of 217
CG5888 resulted in no change to median lifespan on DR and no change on AL (Suppl. Fig. 3C ).
218
RNAi of CG31221 and observed a 26% reduction in median lifespan on DR and no change on 219 AL (Suppl. Fig. 3D ). RNAi of CG15515 resulted in a 5% reduction of median lifespan on DR and 220 no change on AL (Suppl. Fig. 3E ). Based on FlyAtlas data, we induced RNAi of CG5778 in the 221 fat body with the S106-GS-Gal4 and observed 5% reduction of median lifespan on DR and a 222
13% reduction in median lifespan on AL (Suppl. Fig. 3F ). We chose to focus further on our three 223 other candidate genes, dls, Fdxh, and jgh, to determine their role in modulating diet-dependent 224 changes lifespan and healthspan. 225
Of the seven loci downstream of dls associated with climbing regulation (Table 1) , the most 226 significant was found on chromosome 3L at position 16,195,836. At this locus, strains with a G 227 allele showed significant delay in climbing decline over those with a T allele upon DR, but no 228 difference was noted under AL conditions ( Fig. 4A-B ). We examined tissue specificity and 229
mRNA expression changes in response to diet to aid in understanding the mechanism by which 230
diet-dependent changes in phenotypes are mediate. We have previously generated data 231
showing tissue-specific changes in mRNA translation state upon DR (33). With the use of 232
FLAG-tagged ribosomal protein RPL13A, we pulled-down polysomes and analyzed the tissue-233 specific changes in mRNAs upon DR as previously described (33, 84). We observed that dls 234 was moderately elevated in the germline, heart, and muscle (Suppl. Fig 4A) . To test for 235 transcriptional expression changes, we performed qRT-PCR for dls in body segments of w 1118 236 control flies raised on either AL or DR diet for 7 days and saw elevated expression in the 237 abdomen relative to other body segments as well as a nine-fold increase in expression in the 238 head on DR versus AL diet ( Fig 4C) . As there were no RNAi constructs available for this line, 239
we used a line containing a Minos element insertion in dls (Suppl. Fig. 9 ) (85) for our validation 240
experiments. With this mutant line, we observed a ~90% reduction in mRNA expression in DR 241 conditions (Suppl. Fig. 5A-B ). We saw a 19% increase in median lifespan on DR and 8% on AL 242
in a w 1118 background over w 1118 controls ( Fig. 4D ) but a 7% reduction on DR and a 19% 243 reduction in median lifespan on AL in a Canton-S background (Suppl. Fig. 6A ). We found that 244 climbing ability was consistently increased in mutants fed DR over their wildtype controls 245 regardless of strain background, with no significant changes observed in AL conditions ( Fig. 4E , 246
Suppl. Fig 6B) . In total, while the longevity effects of this mutation were mixed depending on 247 strain background there was a significant improvement in climbing ability only observed on a DR 248 diet ( Fig. 4F , Suppl. Fig. 6C ). We also tracked spontaneous activity for these flies for 24 hours 249 (see Methods), and found that the dls mutant had increased spontaneous activity only on the 250 DR diet regardless of strain background (Suppl. Fig. 8 ). Due to its role in regulating climbing and 251 spontaneous activity on DR, we propose the common name Daedalus (dls) for CG33690 after 252 the mythological Greek inventor who created wings to escape incarceration by King Minos. 253
Thus dls, which was identified as a candidate that influences diet-dependent changes in 254 climbing ability, showed consistent effects on healthspan but failed to show consistent effects on 255
lifespan. These data further argue that lifespan and age-related climbing ability are likely to be 256 regulated by distinct mechanisms and that healthspan can be extended without a concomitant 257 increase in lifespan. 258
Through our Interaction GWAS for longevity, we identified an intronic variant in jgh associated 259
with the day at which less 75% of a strain's population was surviving ( Table 1 ). We found that 260 DGRP strains fed the AL diet with a G allele at a particular locus (chr. 2L, position 2,707,945) 261 showed a slightly delayed decline in 75% survival over strains with an A at that locus ( Fig. 5A ). 262
Alternatively, strains with the G allele in DR conditions showed a significantly reduced 75% 263 survival than counterparts with the A allele at the locus of interest (Fig. 5B ). This gene is 264
homologous to the human gene Regulator of G-Protein Signaling 7 Binding Protein (RGS7BP), 265
and was previously noted in a GWAS screen for growth regulators of wing size (86) but has not 266 previously been shown to play a role in longevity nor diet response. From our ribo-tag data we 267
observed an eight-fold increase in jgh expression in the brain under DR conditions, as well as a 268
2.5-fold increase in expression on DR in the fat body and Malpighian tubule (Suppl. Fig. 4B ).
269
Through qRT-PCR we found that both on AL and DR diet jgh is expressed in the thorax, but DR 270 induces a 55-fold increase in expression in the head (Fig. 5C ). Thus, we used a pan-neuronal 271
RU486-inducible Elav-GS-Gal4 driver to examine diet-dependent changes in longevity and 272
health. We observed a 20% increase in median lifespan on an AL diet over control flies with one 273
jgh RNAi strain (v30160, Suppl. Fig. 9, Fig. 5D ) and a 29% increase in median lifespan on AL 274
with a second strain (v30163, Suppl. Fig. 6D ). We propose the name jughead (jgh) for this gene, 275
after the fictional comic book character with a propensity for overeating without suffering its ill 276 effects. In parallel, we examined whether inhibition of jgh will also extend healthspan.
277
Surprisingly, RNAi of jgh failed to show any significant change in age-related climbing ability 278 ( Fig. 5E , Suppl. Fig 6E) . Through qRT-PCR of the heads of flies from these crosses, we again 279 saw elevated expression under DR conditions relative to flies raised on the AL diet, with RNAi-280
inducing approximately 50% reduction in the expression on AL and 70% reduction on DR.
281
(Suppl. Fig. 5C -D). Overall we saw increased longevity on AL with jgh RNAi in neurons but did 282 not see a change in the climbing ability with age ( Fig. 5F , Suppl. Fig. 6F ). Thus, inhibtion of jgh 283 only extends lifespan without significant effects on climbing ability. 284
One locus identified through our Case-Control GWAS for strains with exceptional longevity (see 285
Methods) was position 9,364,312 on chromosome 3L, which falls in an intronic region of the 286 gene Fdxh. At this locus, DGRP strains with a C or A allele showed no difference in average 287 median lifespan on AL ( Fig. 6A ), but under DR the A allele proved beneficial to median lifespan 288 ( Fig. 6B ). Fdxh is involved in ecdysteroid production in flies (87), and human homologs have 289 been implicated in mitochondrial maintenance (88, 89). Results from RPL13A tagging showed 290 that under DR, Fdxh expression was modestly increased in every tissue except the heart and 291 neurons (Suppl. Fig. 4C ), and qRT-PCR results showed that DR induces moderately increased 292 expression in each body segment ( Fig. 6C ). As such, we used Act5C-GS-Gal4 that leads to 293 whole-body RNAi. Inhibition of Fdxh resulted in a 12% reduction in median lifespan on DR with 294 the use of one Fdxh RNAi line (v104499, Suppl. Fig. 9, Fig. 6D ) and a 20% decrease in median 295
lifespan on DR as well as a 19% decrease on AL with the use of another RNAi line (v24497, 296
Suppl. Fig. 9 , Suppl. Fig. 6G ). Using the transgenic line v1014499 we also saw no change in 297
climbing ability at any point in life on either diet (Fig. 6E ), but using v24497 resulted in a 298 reduction in climbing ability in the second week of adulthood on DR (Suppl. Fig. 6H ). In all, we 299
found that whole-body RNAi of Fdxh causes a reduction in lifespan on DR and depending on 300
the genetic background may also cause a reduction on AL, but the age-related climbing ability 301 was unaffected (Fig. 6F, Suppl. 6I ). qRT-PCR of whole body RNAi knockdown flies showed no 302 change between DR and AL expression, with knockdown inducing a 50% reduction in 303 expression (Suppl. Fig. 5E-F Here, we have utilized the DGRP to perform the first longevity and healthspan GWAS featuring 316 two different dietary compositions. We found that DR was beneficial in 83% of strains' median 317 lifespan and 87% of strains' climbing ability, while the remainder of strains showed no effect or 318 negative effects. These results are consistent with previous findings in flies and mice, where 319 different nutrient manipulations failed to induce universal effects across strains (97, 98). Our 320
data also show that longevity and health are not exclusively affected by DR through the same 321 mechanisms, as there was no statistical correlation between median lifespan and either of our 322 climbing measures. Furthermore, through GWAS across all tested lines, we have implicated a 323 number of new longevity and healthspan genes. In validating three of these genes, we also 324
failed to see a correlation between lifespan and age-related climbing ability. Together these 325
results support the argument that lifespan and healthspan are likely to be regulated by distinct 326 genetic mechanisms. 327
The separation of lifespan and health regulation has been a topic of debate. Recent studies 328
have suggested either that lifespan and health are uncoupled in their regulation (41, 42, 44, 99) 329 or that they are correlated (71, 100, 101). One recent report demonstrated that known short-330 lived mutants frequently show a reduction in health by some measures but an extension by 331 others, indicating the complexity of the relationship between lifespan and healthspan (43). It is 332 conceivable that lifespan is uncoupled from healthspan as lifespan is likely to be affected by the 333 weakest link that leads to mortality and thus may not reflect the underlying rate of aging or a 334 particular healthspan trait. Our work here suggests that genotype is a significant contributing 335 factor towards this relationship. One difference between our study and previous reports is that 336 previous work has largely focused on candidate-based targets, whereas we provide the first 337
instance of a direct comparison across a panel of ~150 strains with naturally arising genetic 338 variation. Through our phenotypic analysis of the DGRP, we saw no correlation between 339 climbing ability and length of life. While climbing ability is certainly not the end-all measure for 340
health, it remains one of the most frequently used and trusted methods for assessing overall 341 functional health (49-52, 54, 102). While others have suggested that functional health by means 342 of physical activity should be presented in the context of maximal functionality rather than 343 absolute activity (101), we further observed no correlation with lifespan in either of these 344 contexts (Fig. 3, Suppl. Fig. 2 ). Looking further into our DGRP phenotypic data, we did not 345 observe a correlation between lifespan and our functional health measures in general but also 346 saw that the effects of DR were not exclusively beneficial and in some strains affected lifespan 347 and healthspan differentially. Despite the prevailing notion in the field that lifespan-extending 348
interventions will also extend healthspan, our data argues that lifespan and healthspan can be 349 uncoupled quite often. Further, although DR is widely viewed as one of the most robust means 350
for lifespan and healthspan extension (35), our data suggest that genotype significantly 351
influences the extent and type of benefits one can derive from DR. In human studies of longevity 352
and mortality it has been suggested that a healthy lifestyle can improve healthspan without 353 necessarily altering lifespan, creating a compression of the period of disability (103).
354
Understanding the genetic mechanisms which can contribute to compression or extension of 355 morbidity, particularly in response to dietary influences, will allow for more targeted approaches 356
to diagnosing mortality and maximizing healthspan (104, 105). It is worth noting that sex-specific 357 responses to dietary restriction have been observed across different genotypes (31).
358
Furthermore, using walking speed as a predictor of mortality is suggested to be more effective 359
in men than women (45, 106, 107). In our study we use female flies, and we predict that our 360 results could differ from a study conducted entirely with males. 361
Through GWAS, we were successfully able to pinpoint loci significantly associated with lifespan 362 or climbing regulation. Upon generating a list of statistically significant diet-dependent longevity 363 or health-related loci, we immediately noticed the absence of loci found in genes that take part 364
in the well-studied diet-responsive pathways involved in longevity or health, such as those in the 365 TOR pathway (24). One reason for this could be because polymorphisms that would alter the 366 function of these genes would likely be lethal or inhibit development to adulthood, and thus may 367 not be well-represented in adult wild isolates like the DGRP. A second possibility is that there 368 are many genes which influence lifespan phenotypes and genes in the ILS and TOR pathways 369
represent only a small fraction of those. In support of this argument, over 500 genes have been 370 identified to influence longevity in a variety of models (108), most notably those identified 371 through screens in S. cerevisiae (109) and C. elegans (110, 111). 372
Through our climbing GWAS, we identified a novel role for the gene dls in absolute climbing 373 ability and overall spontaneous activity. Our DGRP strain phenotypes showed several 374 polymorphisms in this gene were associated with the climbing ability only on DR, a diet-specific 375 effect that was mirrored by flies with transposon-based disruption of the dls gene. No biological 376 function has been suggested for this gene, and the protein it encodes contains a conserved 377 domain of unknown function (InterPro DUF1091). We have found that expression of this gene 378 increases dramatically on DR in the head, potentially suggesting a neuronal mechanism 379 influencing climbing ability. Interestingly, the longevity effect of a mutation in this gene varied 380 depending on the strain background. We found significantly increased lifespan on both diets in a 381 w 1118 background but significantly decreased lifespan on the AL diet in a Canton-S background. 382
Despite these differing results, the significant increases in climbing ability and spontaneous 383 activity on DR were observed in both backgrounds, emphasizing that this gene is not a robust 384
modulator of longevity but appears to regulate overall physical function across multiple 385 genotypes. 386
One novel longevity locus we identified through our analyses was in jgh. The homology of jgh to 387 RGS7BP in humans suggests a role in regulating neuronal G protein signaling (112). Through 388 our experiments, we verified a diet-specific role in lifespan regulation through jgh. Although we 389
observed that knockdown of jgh extended lifespan on AL diet, our GWAS association effect was 390 largest on DR. We attribute this difference to the difference between the effects of an intronic 391 single-nucleotide polymorphism in the DGRP strains and RNAi knockdown (113). Human 392
GWAS has previously identified RGS7BP as being associated with schizophrenic and bipolar 393 disorders (114) as well as weight gain in response to antipsychotic medication (115), but a 394 dietary link has not been previously observed. Neuronal G protein-coupled receptors have been 395 implicated in Drosophila insulin-like signaling (116), providing a potential intriguing, diet-396 dependent mechanism for further investigation. We also observed a new role for Fdxh in diet-397 responsive longevity, which has previously been shown to regulate mitochondrial function and 398
Friedrich's ataxia pathology across multiple species (117, 118) and ecdysteroid production in 399 flies (87). Studies in multiple model systems (119-121) and humans (122) have shown the 400 importance of proper Fe-S maintenance and the role of these clusters in proper electron 401 transport in the mitochondria. Given the role of mitochondrial function in diet-dependent effects 402 on longevity (23, 123-126), it is fitting that our screen revealed a role for a mitochondrial gene in 403 lifespan regulation. Additionally, Fdxh has been observed in an array for cycling circadian genes 404 in the head (127). As circadian clocks have been implicated in diet-dependent lifespan 405 extension (4), modulation of circadian phenotypes is another potential mechanism by which 406
Fdxh could modulate diet-specific longevity. One human homolog of Fdxh, FDX1L, has been 407 implicated in inflammatory bowel disease and Crohn's disease (128) and dermatitis (129). 408
Another more distantly related human homolog, COX15, has been found in GWAS for childhood 409 obesity (130), Crohn's disease (131), colorectal cancer (132) , and cardiovascular disease (133), 410
all of which could provide clear impacts on longevity. 411 Together, we have provided a novel approach to understanding the natural genetic factors 412 which regulate diet-dependent changes in longevity and health. By measuring both lifespan and 413 also an age-related component of health, climbing ability in the same strains, we were able to 414 dissect the genetics of two age-related traits simultaneously. Our experiments, using diet 415 manipulation, have further detailed the diversity of responses in wild strains to DR, which varies 416 greatly by genotype both in lifespan and climbing ability. Most previous studies have examined 417 healthspan in known longevity genes, which may be subject to confirmation bias and negative 418
results where lack of correlation between healthspan and lifespan was obtained but under-419
reported. Our study utilized an unbiased approach to examine the relationship between 420 healthspan and lifespan in over 150 strains and manipulation of candidate genes identified from 421 this analysis. Our findings strongly argue for genetic uncoupling of mechanisms that modulate 422 longevity and healthspan. Two to three days post-eclosion, mated female progeny were transferred to AL (5.0% yeast 430 extract) or DR (0.5% yeast extract) diet, as previously described (23, 135). Eight vials of 25 flies 431
were used per diet per strain. Flies were maintained at 25 o C and 65% relative humidity 432 throughout life. Living flies were transferred to fresh vials every other day, with dead flies being 433 recorded, until all flies were dead. One biological replicate (200 animals) was recorded for 107 434 lines, two biological replicates for 52 other lines, and three biological replicates for two other 435 lines. w 1118 was also tested with each batch as an internal control. DGRP lines not tested were 436 not viable long term in our lab. 437
Fly climbing phenotyping. Throughout life, climbing ability was recorded weekly on days 438
between vial transfers for all vials containing 20 or more living flies. The negative geotaxis 439
climbing ability test was adapted from previous methods (136). Flies were placed in an empty 440 vial with a line 6 cm from the bottom. Flies were gently tapped to the bottom of the vial and the 441 number able to cross the line within 10 seconds was recorded. This was repeated three times 442
for each vial, and the percentage of live flies still climbing above the line was averaged for a 443
given line at weekly timepoints throughout life. For normalized climbing values, weekly climbing 444
values were normalized to the percentage of flies climbing one week following placement on AL 445
or DR. We used the day at which flies passed below 50% of their day seven climbing value for 446
genome-wide analysis, as well as the day at which a 20% or less of a surviving population of 447 flies were still able to climb. 448 Genome-wide association analysis. We used DGRP release 2 genotypes, and FlyBase R5 449 coordinates for gene models. As in Nelson et al., 2016 (77) , we used only homozygous 450 positions and a minor allele frequency of ≥25% to ensure that the minor allele was represented 451 by many observations at a given polymorphic locus. The collected phenotype and genotype 452
data were used as input into an association test via ordinary least squares regression using the 453
StatsModels module in Python (137). The linear model was phenotype = β 1 x genotype + β 2 x 454 diet + β 3 x genotype x diet + intercept. Nominal p-values denoted as "genotype" in Table 1 report 455 the probability that β 1 ≠ 0, and those denoted as "interaction" report the probability that β 3 ≠ 0. 456
For the binary "case-control" search for determinants of long lifespan, we used median lifespan 457 thresholds of ≥41 days on AL diet and ≥51 days on DR diet, and a Fisher's exact test comparing 458 the long-lived and short-lived populations with both alleles at a given position. To avoid the 459 potential for false positives at a given nominal cutoff owing to p-value inflation, we calculated 460 false discovery rates via permutation as follows: for a given permutation i, we randomized 461 phenotype values across DGRP lines, retaining the true diet assignment, and on this permuted 462
data set we carried out association tests for each marker in turn as above. We counted the 463 number of markers n i that scored above a given p-value threshold t. We tabulated the false 464 discovery rate (FDR) at t as the ratio between the average n i across ten permutations and the 465 number of markers called at t in the real data. We used an empirical FDR upper bound of 10% 466 within a given analysis to call candidate loci of interest. 467
Gene expression analysis.
To determine gene expression in a normal system, we sampled 468 five whole flies, 50 heads, 50 thoraxes, or 50 abdomens from mated females of w 1118 control 469 strain after one week on AL or DR diet. We isolated RNA using Zymo Quick RNA MiniPrep kit 470
(R1054) (Zymo Research, Irvine, CA). For qRT-PCR, we used Superscript III Platinum SYBR 471
Green One-Step qRT-PCR kit from Invitrogen, Carslbad, CA (11736-051) and followed 472 manufacturer's instructions with a Roche Lightcycler 480 II machine. To validate the effects of 473
RNAi or mutation on gene expression, we collected five whole female bodies or 50 heads 474 following one week on AL or DR. We then isolated RNA from these samples and performed 475
qRT-PCR on the perturbed genes as described. 476
Gene alteration phenotyping. For candidate gene validation, all lines were obtained from 477
Bloomington Stock Center (134) or Vienna Drosophila RNAi Center, Vienna, Austria (138) (see 478
Suppl. Fig. 9 for list of lines used (87, 139-148)). To validate the GWAS-predicted effects of jgh 479
and Fdxh, we used the whole-body GeneSwitch (149) driver Act5C-GS-Gal4 (140) and the 480 neuron-specific driver Elav-GS-Gal4 (139) 
